Clinical trial shows effectiveness in treating mild to moderate forms of the disease, and it may even improve cognitive function.
Read more: https://www.scmp.com/news/china/science/article/3036119/china-approves-oligomannate-worlds-first-new-alzheimers-drug-20?source=Snapzu
No comments:
Post a Comment